504 related articles for article (PubMed ID: 27439500)
1. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
2. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion.
Tseng HC; Cacalano N; Jewett A
Oncotarget; 2015 Apr; 6(11):8947-59. PubMed ID: 25860927
[TBL] [Abstract][Full Text] [Related]
3. Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells.
Tseng HC; Inagaki A; Bui VT; Cacalano N; Kasahara N; Man YG; Jewett A
J Cancer; 2015; 6(9):866-76. PubMed ID: 26284138
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
5. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
[TBL] [Abstract][Full Text] [Related]
6. Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells.
Tseng HC; Arasteh A; Paranjpe A; Teruel A; Yang W; Behel A; Alva JA; Walter G; Head C; Ishikawa TO; Herschman HR; Cacalano N; Pyle AD; Park NH; Jewett A
PLoS One; 2010 Jul; 5(7):e11590. PubMed ID: 20661281
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
8. Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
Schmohl JU; Felices M; Oh F; Lenvik AJ; Lebeau AM; Panyam J; Miller JS; Vallera DA
Cancer Res Treat; 2017 Oct; 49(4):1140-1152. PubMed ID: 28231426
[TBL] [Abstract][Full Text] [Related]
9. Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10.
Bui VT; Tseng HC; Kozlowska A; Maung PO; Kaur K; Topchyan P; Jewett A
Front Immunol; 2015; 6():576. PubMed ID: 26697005
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
11. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
12. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
[TBL] [Abstract][Full Text] [Related]
13. Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy.
Chiang J; Chen PC; Pham J; Nguyen CQ; Kaur K; Raman SS; Jewett A
Front Immunol; 2023; 14():1284669. PubMed ID: 37954598
[TBL] [Abstract][Full Text] [Related]
14. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced resistance of tumor target cells against lysis by interleukin-2-activated killer cells.
Takagi S; Minakuchi J; Okawa H; Yata J
Tohoku J Exp Med; 1989 Feb; 157(2):131-6. PubMed ID: 2496486
[TBL] [Abstract][Full Text] [Related]
16. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells as effectors of selection and differentiation of stem cells: role in resolution of inflammation.
Jewett A; Man YG; Cacalano N; Kos J; Tseng HC
J Immunotoxicol; 2014 Oct; 11(4):297-307. PubMed ID: 24575813
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.
Wu A; Wiesner S; Xiao J; Ericson K; Chen W; Hall WA; Low WC; Ohlfest JR
J Neurooncol; 2007 Jun; 83(2):121-31. PubMed ID: 17077937
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307
[TBL] [Abstract][Full Text] [Related]
20. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
